| Project/Area Number |
21800001
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biomedical engineering/Biological material science
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
HAYASHI Yasuhiro Hokkaido University, 大学院・薬学研究院, 特任助教 (30548178)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥2,821,000 (Direct Cost: ¥2,170,000、Indirect Cost: ¥651,000)
Fiscal Year 2010: ¥1,261,000 (Direct Cost: ¥970,000、Indirect Cost: ¥291,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 肝臓 / siRNAデリバリー / in vivo 機能解析 / マイクロアレイ解析 / 2型糖尿病 / in vivo機能解析 / 遺伝子発現活性 / 細胞分離 |
|---|
| Research Abstract |
First, nucleic acid such as pDNA and siRNA delivery system to the liver was developed. This mission was achieved by optimizing the density of R8 peptide which has high ability to internalize into cell and GALA peptide as pH sensitive fusogenic peptide. Second, a new candidate gene which related the progression of type 2 diabetes was screened by DNA microarray analysis. Third, in vivo functional analysis of this new gene was performed using siRNA. When knocking down for this gene in the liver of type 2 diabetes model mice, significant reduction of both blood glucose level and body weight was observed. Thus, this new gene is promising therapeutic target for type 2 diabetes as well as obesity.
|
